Comparisons of allocating sample size rationally into individual regions under heterogeneous effect size in a multiregional trial by a fixed effect model and a random effect model
ABSTRACT Recently, sponsors and regulatory authorities pay much attention on the multiregional trial because it can shorten the drug lag or the time lag for approval, simultaneous drug development, submission, and approval in the world. However, many studies have shown that genetic determinants may mediate variability among persons in response to a drug. Thus, some therapeutics benefit part of treated patients. It means that the assumption of homogeneous effect size is not suitable for multiregional trials. In this paper, we conduct the sample size determination of a multiregional clinical trial calculated by fixed effect and random effect under the assumption of heterogeneous effect size. The performances of fixed effect and random effect on allocating sample size on a specific region are compared by statistical criteria for consistency between the region of interest and overall results.